A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has a prevalence of over 20% in Western societies. Affected individuals are at risk of developing both cirrhosis and hepatocellular cancer (HCC). Presently there is no cost effective population based means of identifying cirrhotic individuals and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gray, Joe, Chattopadhyay, Dipankar, Beale, Gary S, Patman, Gillian L, Miele, Luca, King, Barry P, Stewart, Stephen, Hudson, Mark, Day, Christopher P, Manas, Derek M, Reeves, Helen L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729079/
https://www.ncbi.nlm.nih.gov/pubmed/19656391
http://dx.doi.org/10.1186/1471-2407-9-271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729079/
https://www.ncbi.nlm.nih.gov/pubmed/19656391
http://dx.doi.org/10.1186/1471-2407-9-271

Ejemplares similares